SK69699A3 - 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists - Google Patents

2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists Download PDF

Info

Publication number
SK69699A3
SK69699A3 SK696-99A SK69699A SK69699A3 SK 69699 A3 SK69699 A3 SK 69699A3 SK 69699 A SK69699 A SK 69699A SK 69699 A3 SK69699 A3 SK 69699A3
Authority
SK
Slovakia
Prior art keywords
compound
compounds
dosage range
hydrogen
unsubstituted
Prior art date
Application number
SK696-99A
Other languages
English (en)
Slovak (sk)
Inventor
Thomas Lee Cupps
Sophie Eva Bogdan
Raymond Todd Henry
Russell James Sheldon
Villiam Lee Seibel
Jeffrey Joseph Ares
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of SK69699A3 publication Critical patent/SK69699A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
SK696-99A 1996-11-25 1999-05-25 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists SK69699A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3174096P 1996-11-25 1996-11-25
PCT/US1997/020551 WO1998023609A1 (fr) 1996-11-25 1997-11-21 Composes 2-imidazolinylamino-indazole utiles en tant qu'agonistes de l'adrenorecepteur alpha-2

Publications (1)

Publication Number Publication Date
SK69699A3 true SK69699A3 (en) 2000-06-12

Family

ID=21861136

Family Applications (1)

Application Number Title Priority Date Filing Date
SK696-99A SK69699A3 (en) 1996-11-25 1999-05-25 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists

Country Status (20)

Country Link
EP (1) EP0944620A1 (fr)
JP (1) JP2001506599A (fr)
KR (1) KR20000069104A (fr)
CN (1) CN1244864A (fr)
AR (1) AR010643A1 (fr)
AU (1) AU5433998A (fr)
BR (1) BR9713535A (fr)
CA (1) CA2272644A1 (fr)
CO (1) CO4910166A1 (fr)
CZ (1) CZ183999A3 (fr)
HU (1) HUP9904660A3 (fr)
ID (1) ID22676A (fr)
IL (1) IL130067A0 (fr)
NO (1) NO992502L (fr)
NZ (1) NZ335882A (fr)
PE (1) PE47099A1 (fr)
SK (1) SK69699A3 (fr)
TR (1) TR199901542T2 (fr)
WO (1) WO1998023609A1 (fr)
ZA (1) ZA9710576B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
US6433186B1 (en) 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
US20100311965A1 (en) 2007-12-28 2010-12-09 Carna Biosciences Inc. 2-aminoquinazoline derivative
WO2010074753A1 (fr) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Dispositifs d'inhalation et procédés associés pour administration de composés hypnotiques sédatifs
CN112538074A (zh) * 2020-12-24 2021-03-23 艾希尔（深圳）药物研发有限公司 一种溴莫尼定脱溴杂质的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641782A5 (en) * 1978-12-07 1984-03-15 Siegfried Ag 1H- and 2H-indazole derivatives
US4526898A (en) * 1980-09-05 1985-07-02 Siegfried Aktiengesselschaft Antihypertensive 4-(2-imidazolin-2-yl-amino)-2-methyl-indazole
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
ATE194771T1 (de) * 1993-12-17 2000-08-15 Procter & Gamble 6-(2-imidazolinylamino) chinoxalin-verbindungen als alpha-2-adrenorezeptoragonisten

Also Published As

Publication number Publication date
CA2272644A1 (fr) 1998-06-04
CZ183999A3 (cs) 1999-11-17
NO992502L (no) 1999-07-26
PE47099A1 (es) 1999-06-12
EP0944620A1 (fr) 1999-09-29
NZ335882A (en) 2000-12-22
AU5433998A (en) 1998-06-22
JP2001506599A (ja) 2001-05-22
IL130067A0 (en) 2000-02-29
TR199901542T2 (xx) 2000-01-21
WO1998023609A1 (fr) 1998-06-04
ID22676A (id) 1999-12-09
AR010643A1 (es) 2000-06-28
NO992502D0 (no) 1999-05-25
HUP9904660A3 (en) 2002-02-28
CO4910166A1 (es) 2000-04-24
ZA9710576B (en) 1998-09-16
BR9713535A (pt) 2000-03-21
KR20000069104A (ko) 2000-11-25
CN1244864A (zh) 2000-02-16
HUP9904660A2 (hu) 2000-06-28

Similar Documents

Publication Publication Date Title
ES2225998T3 (es) Compuestos (2-imidazolinilamino)indol utiles como agonistas del adrenorreceptor alfa 2.
US6117871A (en) 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists
US6225331B1 (en) Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
US5916900A (en) 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
US6110952A (en) 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
SK69699A3 (en) 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
US6306877B1 (en) Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
EP0944601B1 (fr) Composes heterocycliques guanidinylamino utiles en tant qu'agonistes de l'adrenorecepteur alpha-2
US6172095B1 (en) Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
AU6514498A (en) 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 adrenoceptor agonists
CZ20001912A3 (cs) 5-(2-Imidazolinylamino)-benzimidazolové deriváty, jejich příprava a jejich použití jako alfa adrenoceptorové agonisty se zlepšenou metabolickou stálostí